The ROE as of July 2025 (TTM) for Avid Bioservices, Inc. (CDMO) is -176.54%

According to Avid Bioservices, Inc.’s latest financial reports and current stock price. The company's current ROE is -176.54%. This represents a change of 178.25% compared to the average of -63.45% of the last 4 quarters.

Avid Bioservices, Inc. (CDMO) Historical ROE (quarterly & annually)

How has CDMO ROE performed in the past?

The mean historical ROE of Avid Bioservices, Inc. over the last ten years is -45.67%. The current -176.54% ROE has changed 286.58% with respect to the historical average. Over the past ten years (40 quarters), CDMO's ROE was at its highest in in the April 2022 quarter at 66.24%. The ROE was at its lowest in in the April 2024 quarter at -202.18%.

Avid Bioservices, Inc. (CDMO) ROE by Quarter and Year

Discovering the peaks and valleys of Avid Bioservices, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Avid Bioservices, Inc. (CDMO) Average ROE

How has CDMO ROE performed in the past?

The current ROE of Avid Bioservices, Inc. (CDMO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Avid Bioservices, Inc. (CDMO) ROE vs. Peers

How is CDMO’s ROE compared to its peers?

Avid Bioservices, Inc.’s ROE is greater than Anebulo Pharmaceuticals, Inc. (-90.11%), greater than Adagene Inc. (-76.84%), greater than Acrivon Therapeutics, Inc. Common Stock (-44.66%), greater than AnaptysBio, Inc. (-282.47%), greater than Mineralys Therapeutics, Inc. (-71.15%), greater than Crinetics Pharmaceuticals, Inc. (-30.95%), less than Cytokinetics, Incorporated (801.26%), greater than Cerevel Therapeutics Holdings, Inc. (-42.73%), greater than Bicycle Therapeutics plc (-25.11%), greater than Chinook Therapeutics, Inc. (-41.23%), greater than Immunocore Holdings plc (-5.86%), greater than Mirum Pharmaceuticals, Inc. (-33.63%), greater than Larimar Therapeutics, Inc. (-52.48%), greater than KalVista Pharmaceuticals, Inc. (-106.83%), greater than Lyra Therapeutics, Inc. (-474.37%), less than DICE Therapeutics, Inc. (56.07%), greater than Edgewise Therapeutics, Inc. (-30.95%), greater than Karuna Therapeutics, Inc. (-36.44%), greater than Dyne Therapeutics, Inc. (-52.83%), greater than IDEAYA Biosciences, Inc. (-29.20%), greater than MeiraGTx Holdings plc (-241.89%), less than Keros Therapeutics, Inc. (0.75%), greater than Homology Medicines, Inc. (-447.33%),

Build a custom stock screener for Avid Bioservices, Inc. (CDMO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avid Bioservices, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Avid Bioservices, Inc. (CDMO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Avid Bioservices, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.